Alzheimer's Drug Improves Memory and Cognition in Multiple Sclerosis Patients

Alzheimer’s Drug Improves Memory, Cognition in MS Patients
NewsWise - A drug widely used for treating dementia in Alzheimer’s patients has been shown to improve memory and cognition in multiple sclerosis (MS) patients who are mild to moderately cognitively impaired.

Most MS patients and their doctors focus primarily on managing the physical manifestations that characterize the disease, yet an estimated 50 percent of the patients will also face varying degrees of cognitive impairment. Cognitive impairment can include difficulties with problem-solving, attention, learning and memory, and can lead to loss of jobs, social withdrawal, and changes in mood. Only 10 percent of all MS patients will experience severe cognitive impairment, but even mild impairment can interfere significantly in a patient’s life.